Show simple item record

dc.contributor.authorEfeyan, Alejo
dc.contributor.authorZoncu, Roberto
dc.contributor.authorSabatini, David
dc.date.accessioned2017-02-10T19:20:14Z
dc.date.available2017-02-10T19:20:14Z
dc.date.issued2012-09
dc.identifier.issn1471-4914
dc.identifier.urihttp://hdl.handle.net/1721.1/106904
dc.description.abstractThe mechanistic target of rapamycin (mTOR) kinase controls growth and metabolism, and its deregulation underlies the pathogenesis of many diseases, including cancer, neurodegeneration, and diabetes. mTOR complex 1 (mTORC1) integrates signals arising from nutrients, energy, and growth factors, but how exactly these signals are propagated await to be fully understood. Recent findings have placed the lysosome, a key mediator of cellular catabolism, at the core of mTORC1 regulation by amino acids. A multiprotein complex that includes the Rag GTPases, Ragulator, and the v-ATPase forms an amino acid-sensing machinery on the lysosomal surface that affects the decision between cell growth and catabolism at multiple levels. The involvement of a catabolic organelle in growth signaling may have important implications for our understanding of mTORC1-related pathologies.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grants R01 CA129105, R01 CA103866, and R37 AI047389)en_US
dc.description.sponsorshipAmerican Federation for Aging Researchen_US
dc.description.sponsorshipStarr Foundationen_US
dc.description.sponsorshipDavid H. Koch Institute for Integrative Cancer Research at MIT. Frontier Research Programen_US
dc.description.sponsorshipEllison Medical Foundationen_US
dc.description.sponsorshipJane Coffin Childs Memorial Fund for Medical Research (Fellowship)en_US
dc.description.sponsorshipLAM Foundationen_US
dc.description.sponsorshipHuman Frontier Science Program (Strasbourg, France)en_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttps://dx.doi.org/10.1016/j.molmed.2012.05.007en_US
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourcePMCen_US
dc.titleAmino acids and mTORC1: from lysosomes to diseaseen_US
dc.typeArticleen_US
dc.identifier.citationEfeyan, Alejo, Roberto Zoncu, and David M. Sabatini. “Amino Acids and mTORC1: From Lysosomes to Disease.” Trends in Molecular Medicine 18.9 (2012): 524–533.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentWhitehead Institute for Biomedical Researchen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorEfeyan, Alejo
dc.contributor.mitauthorZoncu, Roberto
dc.contributor.mitauthorSabatini, David
dc.relation.journalTrends in Molecular Medicineen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsEfeyan, Alejo; Zoncu, Roberto; Sabatini, David. M.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-1446-7256
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record